InvestorsHub Logo
Followers 68
Posts 15875
Boards Moderated 0
Alias Born 10/13/2005

Re: chalmer post# 181256

Thursday, 05/22/2014 3:21:10 PM

Thursday, May 22, 2014 3:21:10 PM

Post# of 211623
It would be easier to get excited if the PR's were somewhat realistic.

The patent the company has acquired, ( http://ih.advfn.com/p.php?pid=nmona&article=60415236 ) is about 5 years old and needs to go through testing and FDA trials before approval. That will take some time.

There is a period that the patent holder has exclusive on the product, but it's from the date of patent issue and not production. After that, generics kick in with no compensation.

North County Clinical Research ( http://ih.advfn.com/p.php?pid=nmona&article=61887961 ) looks OK, but small. What
BioRegenerative Sciences has to offer is IMHO, questionable.
My brief research on them shows them to be like a hair club for women. Not sure how they would fit in.

The oil and gas PR's are over the top. The supply is tightly controlled as are all form of distribution. Contracts are generally long term and buyers stick to reputable suppliers to ensure continued supply. This company doesn't have the funds to deal in that sector. The 50m funding from the bone cruncher wouldn't be enough to start.

PR's like the oil one don't work anymore. That may have caused a run 10 years ago, but investors are getting smarter.


It really doesn't help that the company has a history of failure and a rising OS. Those 144 filings don't help either.



Remember........ It's better to wish you had bought a
stock, than to wish you hadn't.